Related Experiment Videos

Orthotopic cardiac transplantation for dilated cardiomyopathy after allogeneic bone marrow transplantation

P S Ramrakha1, D I Marks, S G O'Brien

  • 1Department of Haematology, Royal Postgraduate Medical School, London, U.K.

Clinical Transplantation
|February 1, 1994
PubMed

Insights

This case study details a patient with acute myeloid leukemia (AML) who received a bone marrow transplant (BMT). He later required a heart transplant due to cardiomyopathy, achieving full recovery.

Area of Science:

  • Hematology
  • Cardiology
  • Transplantation Medicine

Background:

  • Acute myeloid leukemia (AML) is a serious hematologic malignancy.
  • Bone marrow transplantation (BMT) is a curative treatment for AML.
  • Cardiomyopathy can be a serious complication post-BMT.

Observation:

  • A 26-year-old man with AML underwent BMT from an HLA-identical sibling donor.
  • Nine months post-BMT, he developed dilated cardiomyopathy.
  • He subsequently underwent orthotopic heart transplantation.

Findings:

  • The patient achieved complete hematological remission of AML.
  • He demonstrated normal cardiac function post-heart transplantation.
  • This is the first reported case of cardiac transplantation following BMT.

Implications:

  • Cardiac transplantation is a viable option for managing severe cardiomyopathy after BMT.
  • This case expands the understanding of managing complex post-transplant complications.
  • Further research may explore the long-term outcomes of cardiac transplantation in BMT recipients.

Related Concept Videos